{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:18:45Z","timestamp":1779322725867,"version":"3.51.4"},"reference-count":36,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Juvenile myelomonocytic leukemia (JMML) is a fatal pediatric cancer characterized by classical features such as splenomegaly, monocytosis, and granulocyte-macrophage colony-stimulating factor (GM-CSF) hypersensitivity, with RAS pathway mutations being the major drivers. Mutations causing loss-of-function of the Neurofibromin 1 gene (NF1LOF) occur in \u223c20% of patients with JMML. NF1LOF drives upregulation of RAS\/MAPK\/PI3K pathways that leads to aggressive proliferation\/differentiation of immature myeloid cells. Hematopoietic stem cell transplantation is the only curative option, but relapse occurs in \u223c50% of patients, indicating an urgent need for novel and targeted therapeutic strategies. However, low patient sample availability and a lack of reliable disease models have made it difficult to study and treat JMML. Using CRISPR\/Cas9, we have generated NF1LOF in human umbilical cord blood-derived hematopoietic stem and progenitor cells (HSPCs). We achieved a high gene knockout rate of \u223c89% and concomitant loss of NF1 protein in the modified HSPCs. Importantly, NF1LOF cells displayed marked GM-CSF hypersensitivity in in vitro colony-forming unit assays, mirroring JMML. When transplanted into NSG-SGM3 mice, they caused rapid lethality (median survival of 32 days), myeloid expansion, tissue infiltration (spleen, liver, and lungs), and specific upregulation of RAS\/MAPK pathway and STAT5 genes, consistent with patient profiles. This first humanized NF1LOF mouse model recapitulates key JMML features, enabling investigation of disease mechanisms and targeted therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024015191","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T17:50:34Z","timestamp":1762537834000},"page":"837-849","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Novel humanized loss-of-function\n                    <i>NF1<\/i>\n                    mouse model of juvenile myelomonocytic leukemia"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6971-2725","authenticated-orcid":false,"given":"Roshani","family":"Sinha","sequence":"first","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"},{"name":"2Department of Surgery, University of California San Francisco, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9918-5564","authenticated-orcid":false,"given":"Rachana Vinay","family":"Patil","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Romano","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3801-7276","authenticated-orcid":false,"given":"Devesh","family":"Sharma","sequence":"additional","affiliation":[{"name":"2Department of Surgery, University of California San Francisco, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esmond","family":"Lee","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhonda","family":"Perriman","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Takeda","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin J.","family":"Lesch","sequence":"additional","affiliation":[{"name":"2Department of Surgery, University of California San Francisco, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Yao","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-8338","authenticated-orcid":false,"given":"Y. Lucy","family":"Liu","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8198-5010","authenticated-orcid":false,"given":"M. Kyle","family":"Cromer","sequence":"additional","affiliation":[{"name":"2Department of Surgery, University of California San Francisco, San Francisco, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-2498","authenticated-orcid":false,"given":"Matthew H.","family":"Porteus","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"},{"name":"3Bass Center for Childhood Cancer and Blood Diseases, Lucile Packard Children's Hospital, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3729-436X","authenticated-orcid":false,"given":"Alice","family":"Bertaina","sequence":"additional","affiliation":[{"name":"1Division of Pediatrics Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, CA"},{"name":"3Bass Center for Childhood Cancer and Blood Diseases, Lucile Packard Children's Hospital, Stanford University, Stanford, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"7","key":"2026021015533131000_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood-2014-08-550483","article-title":"How I treat juvenile myelomonocytic leukemia","volume":"125","author":"Locatelli","year":"2015","journal-title":"Blood"},{"issue":"2","key":"2026021015533131000_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3324\/haematol.2009.016865","article-title":"Molecular basis of juvenile myelomonocytic leukemia","volume":"95","author":"De Vries","year":"2010","journal-title":"Haematologica"},{"issue":"11","key":"2026021015533131000_bib3","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ng.3400","article-title":"The genomic landscape of juvenile myelomonocytic leukemia","volume":"47","author":"Stieglitz","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"2026021015533131000_bib4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng0296-137","article-title":"Nf1 deficiency causes Ras-dediated granulocyte\/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia","volume":"12","author":"Largaespada","year":"1996","journal-title":"Nat Genet"},{"issue":"5","key":"2026021015533131000_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V77.5.925.925","article-title":"Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors","volume":"77","author":"Emanuel","year":"1991","journal-title":"Blood"},{"key":"2026021015533131000_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a010118","article-title":"NF1 gene and neurofibromatosis 1","volume":"151","author":"Rasmussen","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"9","key":"2026021015533131000_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199403033300903","article-title":"Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders","volume":"330","author":"Shannon","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"2026021015533131000_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood.V92.1.267.413a31_267_272","article-title":"Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1","volume":"92","author":"Side","year":"1998","journal-title":"Blood"},{"issue":"1","key":"2026021015533131000_bib9","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood-2004-05-1944","article-title":"Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/EBMT trial","volume":"105","author":"Locatelli","year":"2005","journal-title":"Blood"},{"issue":"15","key":"2026021015533131000_bib10","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood-2015-05-646216","article-title":"Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy","volume":"127","author":"Liu","year":"2016","journal-title":"Blood"},{"issue":"15","key":"2026021015533131000_bib11","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1182\/bloodadvances.2020002326","article-title":"Sustained fetal hematopoiesis causes juvenile death from leukemia: evidence from a dual-age-specific mouse model","volume":"4","author":"Vara","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"2026021015533131000_bib12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.leukres.2008.09.036","article-title":"PTEN deficiency is a common defect in juvenile myelomonocytic leukemia","volume":"33","author":"Liu","year":"2009","journal-title":"Leuk Res"},{"issue":"6","key":"2026021015533131000_bib13","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/s41375-019-0662-y","article-title":"Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment","volume":"34","author":"Caye","year":"2020","journal-title":"Leukemia"},{"issue":"5","key":"2026021015533131000_bib14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3324\/haematol.2015.138545","article-title":"Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-\/-\u03b3c-\/- mice","volume":"101","author":"Krombholz","year":"2016","journal-title":"Haematologica"},{"issue":"4","key":"2026021015533131000_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood-2017-01-763219","article-title":"Robust patient-derived xenografts of MDS\/MPN overlap syndromes capture the unique characteristics of CMML and JMML","volume":"130","author":"Yoshimi","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2026021015533131000_bib16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41375-021-01331-0","article-title":"Exploring the genetic and epigenetic origins of juvenile myelomonocytic leukemia using newborn screening samples","volume":"36","author":"Behnert","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"2026021015533131000_bib17","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"issue":"2","key":"2026021015533131000_bib18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nprot.2017.143","article-title":"CRISPR\/Cas9 genome editing in human hematopoietic stem cells","volume":"13","author":"Bak","year":"2018","journal-title":"Nat Protoc"},{"key":"2026021015533131000_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtn.2018.04.017","article-title":"Priming human repopulating hematopoietic stem and progenitor cells for Cas9\/sgRNA gene targeting","volume":"12","author":"Charlesworth","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"2026021015533131000_bib20","doi-asserted-by":"crossref","first-page":"e214","DOI":"10.1038\/mtna.2014.64","article-title":"COSMID: a web-based tool for identifying and validating CRISPR\/Cas off-target sites","volume":"3","author":"Cradick","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026021015533131000_bib21","volume-title":"Partek\u2122 Flow\u2122, [computer software]","author":"Partek, an Illumina company","year":"2024"},{"issue":"8","key":"2026021015533131000_bib22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat Med"},{"issue":"2","key":"2026021015533131000_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood.V95.2.639","article-title":"Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors","volume":"95","author":"Emanuel","year":"2000","journal-title":"Blood"},{"issue":"11","key":"2026021015533131000_bib24","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1038\/bcj.2013.56","article-title":"Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia","volume":"3","author":"Hasegawa","year":"2013","journal-title":"Blood Cancer J"},{"issue":"1","key":"2026021015533131000_bib25","first-page":"1","article-title":"Juvenile myelomonocytic leukemia-A comprehensive review and recent advances in management","volume":"11","author":"Gupta","year":"2021","journal-title":"Am J Blood Res"},{"issue":"2","key":"2026021015533131000_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/bjh.19190","article-title":"Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup","volume":"204","author":"Ramamoorthy","year":"2024","journal-title":"Br J Haematol"},{"issue":"4","key":"2026021015533131000_bib27","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2008.08.014","article-title":"Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates","volume":"14","author":"Kotecha","year":"2008","journal-title":"Cancer Cell"},{"issue":"11","key":"2026021015533131000_bib28","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ng.3400","article-title":"The genomic landscape of juvenile myelomonocytic leukemia","volume":"47","author":"Stieglitz","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"2026021015533131000_bib29","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jdcr.2020.08.030","article-title":"Leukemia cutis in a child with juvenile myelomonocytic leukemia presenting with Sweet syndrome\u2013like lesions and a history of multiple juvenile xanthogranulomas","volume":"6","author":"Quek","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"2","key":"2026021015533131000_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3324\/haematol.2009.010355","article-title":"Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1","volume":"95","author":"Steinemann","year":"2010","journal-title":"Haematologica"},{"issue":"2","key":"2026021015533131000_bib31","doi-asserted-by":"crossref","first-page":"e20180853","DOI":"10.1084\/jem.20180853","article-title":"Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia","volume":"218","author":"Louka","year":"2021","journal-title":"J Exp Med"},{"issue":"2","key":"2026021015533131000_bib32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/sj.leu.2403222","article-title":"NOD\/SCID mice engineered to express human IL-3, GM-CSF and steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration","volume":"18","author":"Nicolini","year":"2004","journal-title":"Leukemia"},{"issue":"12","key":"2026021015533131000_bib33","doi-asserted-by":"crossref","first-page":"e0209034","DOI":"10.1371\/journal.pone.0209034","article-title":"Improved multilineage human hematopoietic reconstitution and function in NSGS mice","volume":"13","author":"Wunderlich","year":"2018","journal-title":"PLoS One"},{"issue":"suppl 1","key":"2026021015533131000_bib34","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2018-99-114918","article-title":"DNA methylation subgroups in juvenile myelomonocytic leukemia: an international collaborative analysis and development of a common diagnostic platform","volume":"132","author":"Schoenung","year":"2018","journal-title":"Blood"},{"key":"2026021015533131000_bib35","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-017-02178-9","article-title":"Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia","volume":"8","author":"Stieglitz","year":"2017","journal-title":"Nat Commun"},{"issue":"21","key":"2026021015533131000_bib36","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.3390\/cancers15215204","article-title":"Epigenetic profiling of PTPN11 mutant JMML hematopoietic stem and progenitor cells reveals an aberrant histone landscape","volume":"15","author":"Sinha","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/837\/2502263\/blooda_adv-2024-015191-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/837\/2502263\/blooda_adv-2024-015191-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:53:44Z","timestamp":1770756824000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/3\/837\/548111\/Novel-humanized-loss-of-function-NF1-mouse-model"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024015191","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,10]]},"published":{"date-parts":[[2026,2,2]]}}}